Faculty who have authored publication Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.
Name | Title | Department | Institution |
---|---|---|---|
Bronwen E. Shaw MBChB, PhD | Center Director, Professor | Medicine | Medical College of Wisconsin |